Annual Secretarial Compliance Report for the year ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd has submitted its Annual Secretarial Compliance Report for FY ending March 31, 2025, as required under SEBI Listing Regulations. The review was conducted by Manoj Parakh & Associates, Practicing Company Secretaries. One non-compliance was flagged: the company filed its Related Party Transaction (RPT) disclosure under Regulation 23(9) for the half year ended March 31, 2024, one day late due to a technical glitch on BSE's portal. BSE imposed a fine of Rs. 5,000 plus GST, which the company has since paid. A previously reported board composition issue (lack of woman independent director and independent directors being less than half of board strength) was resolved by appointing Ms. Priyanka Agarwal as Independent Director effective October 17, 2023, and the earlier fine was withdrawn by BSE. All other SEBI regulation compliances, including insider trading, secretarial standards, and disclosure requirements, were found to be in order.
The compliance lapses are minor and have been remediated, with negligible financial impact from the small fine. No material risk to shareholders, and the overall compliance status is satisfactory.